ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000267263.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.047734495	Sensitive
ENSG00000267263.1	ABT-263 (navitoclax)	Colon adenocarcinoma	0.008636593	Sensitive